株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

前臨床イメージング (in-vivo) の世界市場

Preclinical Imaging (In-VIVO)

発行 Global Industry Analysts, Inc. 商品コード 908755
出版日 ページ情報 英文 88 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.93円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
前臨床イメージング (in-vivo) の世界市場 Preclinical Imaging (In-VIVO)
出版日: 2019年10月01日 ページ情報: 英文 88 Pages
概要

当レポートでは、世界の前臨床イメージング (in-vivo:生体内画像) の市場について分析し、全体的な市場規模の実績値・予測値や、主な市場促進・抑制要因、セグメント別および企業別の市場シェア動向 (過去9年間・今後8年間分)、今後の市場成長の方向性、各地域・主要国の市場の詳細動向などを調査すると共に、主要企業のプロファイルなどの情報を取りまとめてお届けいたします。

第1章 分析手法

第2章 エグゼクティブ・サマリー

  • 市場概要
    • 企業別の市場シェア構造 (最新値・予測値)
  • 代表的企業の分析
  • 市場の動向と促進要因
  • 世界市場の将来展望
    • 市場規模・シェアの動向見通し:地域別/国別
    • セグメント別 (画像診断装置、試薬)
      • 市場規模:地域別/国別 (過去9年間・今後8年間分)
      • 市場シェア:地域別/国別 (通算17年間分)

第3章 市場分析

  • 地域別の市場分析
  • 米国
    • 市場の基本データ
    • 企業別市場シェア
    • 前臨床イメージングの市場規模 (実績値・予測値)
    • セグメント別の市場規模 (実績値・予測値)
  • カナダ
  • 日本
  • 中国
  • 欧州 (フランス、ドイツ、イタリア、英国など)
  • アジア太平洋地域
  • 他の国々 (RoW)

第4章 企業

  • ASPECT IMAGING
  • BRUKER CORPORATION
  • 富士フイルムホールディングス
  • LI-COR, INC. (LI-COR BIOSCIENCES)
  • MILABS BV
  • MR SOLUTIONS
  • MEDISO
  • MILTENYI BIOTEC GMBH
  • PERKINELMER
  • TRIFOIL IMAGING

第5章 関連分析

目次
Product Code: MCP14177

Preclinical Imaging (In-VIVO) market worldwide is projected to grow by US$361.3 Million, driven by a compounded growth of 5.9%. Preclinical imaging modalities, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$686 Million by the year 2025, Preclinical imaging modalities will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$16.7 Million to the region's size and clout in the next 5 to 6 years. Over US$16.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Preclinical imaging modalities will reach a market size of US$53.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.7% over the next couple of years and add approximately US$62.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Aspect Imaging; Bruker Corporation; FUJIFILM Holdings Corporation; LI-COR, Inc. (LI-COR Biosciences); Mediso Ltd. ; MILabs BV; Miltenyi Biotec GmbH; MR Solutions Ltd.; PerkinElmer, Inc.; Trifoil Imaging, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Preclinical Imaging (In-VIVO) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Preclinical Imaging (In-VIVO) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Preclinical Imaging (In-VIVO) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Preclinical Imaging (In-VIVO) Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Preclinical imaging modalities (Segment) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Preclinical imaging modalities (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Preclinical imaging modalities (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Preclinical imaging reagents (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Preclinical imaging reagents (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Preclinical imaging reagents (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Preclinical Imaging (In-VIVO) Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Preclinical Imaging (In-VIVO) Market Estimates and Projections in US$ Thousand by Segment: 2018 to 2025
    • TABLE 11: Preclinical Imaging (In-VIVO) Market in the United States by Segment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 12: United States Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025
    • TABLE 14: Canadian Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017
    • TABLE 15: Preclinical Imaging (In-VIVO) Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 17: Preclinical Imaging (In-VIVO) Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017
    • TABLE 18: Japanese Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 20: Preclinical Imaging (In-VIVO) Historic Market Analysis in China in US$ Thousand by Segment: 2009-2017
    • TABLE 21: Chinese Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Preclinical Imaging (In-VIVO) Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Preclinical Imaging (In-VIVO) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 23: Preclinical Imaging (In-VIVO) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 24: European Preclinical Imaging (In-VIVO) Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025
    • TABLE 26: Preclinical Imaging (In-VIVO) Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017
    • TABLE 27: European Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Preclinical Imaging (In-VIVO) Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 29: French Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017
    • TABLE 30: French Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Preclinical Imaging (In-VIVO) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 32: German Preclinical Imaging (In-VIVO) Historic Market Analysis in US$ Thousand by Segment: 2009-2017
    • TABLE 33: German Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 35: Preclinical Imaging (In-VIVO) Historic Market Analysis in Italy in US$ Thousand by Segment: 2009-2017
    • TABLE 36: Italian Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 38: Preclinical Imaging (In-VIVO) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017
    • TABLE 39: United Kingdom Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025
    • TABLE 41: Preclinical Imaging (In-VIVO) Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017
    • TABLE 42: Rest of Europe Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 43: Preclinical Imaging (In-VIVO) Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 44: Asia-Pacific Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017
    • TABLE 45: Asia-Pacific Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 46: Rest of World Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025
    • TABLE 47: Rest of World Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017
    • TABLE 48: Preclinical Imaging (In-VIVO) Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

IV. COMPETITION

  • ASPECT IMAGING
  • BRUKER CORPORATION
  • FUJIFILM HOLDINGS CORPORATION
  • LI-COR, INC. (LI-COR BIOSCIENCES)
  • MILABS BV
  • MR SOLUTIONS
  • MEDISO
  • MILTENYI BIOTEC GMBH
  • PERKINELMER
  • TRIFOIL IMAGING

V. CURATED RESEARCH

Back to Top